• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

New study finds surprising link between statins and cataracts

June 22, 2022 by David Barret Leave a Comment

Statins, a drug to lower LDL (bad cholesterol), are consumed by more than 40,000,000 Americans. They are the most popular prescription drug class in the United States. Some of the most commonly prescribed statins include atorvastatin.

Side effects can occur, including lowering your cholesterol and decreasing your chances of suffering from a stroke. There are some negative side effects, including memory loss, brain damage, kidney damage, and liver disease, but these are rare. You are also at higher risk for developing cataracts.
Cataracts cause vision impairment by creating cloudy regions within the eye. They usually develop slowly over time, affecting either one or both eyes and causing blurry vision. They can most often be treated by surgery that restores vision.

Research Highlights

Large-scale genotyping and exome sequence analysis from the UK Biobank were used by researchers to examine the potential effects of long-term statin usage on cataract risk.

The analysis revealed that common variants in genetics found in more than 402,000 people and not on statins mimicked the effects of LDL cholesterol-lowering statins and were associated higher risk for cataracts.

They also found that rare genetic variations in 169,172 people, which mimic statin treatment, almost doubled the risk of developing eye problems.
New research suggests that those who have LDL-cholesterol levels similar to statin drugs may have a greater chance of developing cataracts. This is according to the Journal of the American Heart Association. JAHA is an American Heart Association open-access peer-reviewed journal.

Some evidence has been found that statin medications can increase the chance of developing cataracts. Researchers examined whether certain genes that mimic the action of statins could increase the risk of developing cataracts.

Statin medications decrease LDL-cholesterol levels by blocking an enzyme called HMG/CoA-reductase. Research has shown that variants in HMGCR genes can alter how cholesterol is metabolized.

“We were able a establish a link among genetic variants that mimic HMGCR and development of cataracts,” Jonas Ghouse was the lead study author. Jonas Ghouse is a fellow of the cardiac genetics team, Laboratory for Molecular Cardiology within the department of biomedical science at the University of Copenhagen, Denmark. “We could not find any association with statins or other lipid-lowering medications. The benefits of statins to lower blood cholesterol in those with high blood cholesterol are far greater than the risk of cataracts.

Researchers analyzed genetic data from more than 402,000 people using the UK Biobank. Researchers identified five genetic variants that could lower LDL cholesterol. The researchers then calculated the genetic score based on each variant’s impact on LDL cholesterol. A genetic analysis was done to find carriers of a rare mutation found in the HMGCR genes, which is known as a predicted loss of function mutation.

Ghouse stated that “when we carry a Loss-of-function mutation, it is less likely that the gene will work.” “The body can’t make that protein if this gene doesn’t function.” Simply put, the HMGCR loss-of-function mutation equals taking statin medication.

The study showed:

HMGCR genetic risk scores identified people who were at higher risk of having cataract surgery or cataracts. The genetic score associated each 38.7 mg/dL decline in LDL cholesterol with a 14% increased risk of cataracts and a 25 percent higher risk for cataract surgery.

32 out of the 169,172 HMGCR sequencing results showed that they had one of 17 rare HMGCR loss-of-function mutants. These rare mutations had a significantly higher risk of developing cataracts than those without them.

Ghouse said that he was amazed at the scale of the association. “The main difference in the two analyses was that loss-of-function mutations are much more dangerous than common variants. It mimics medication-induced changes,” he explained. “We believe that the true impact lies closer to the loss/function mutation association than the common-variant association. Statins cause almost complete inhibition of the protein. A loss-of-function mutation can also lead to a markedly reduced ability for that protein to be produced.

The study’s major drawback is that while the genetic variants carry a lifetime risk of developing cataracts, they should not be evaluated for people who start statins later on in life due to their positive effects on blood cholesterol. These findings require further evaluation in clinical trials.
Ghouse stated that statin treatment tends to be more common later in life. “However,” Ghouse said, “But, there are certain patients who are diagnosed early with high cholesterol. These patients start statin therapy at a young age to help them be detected and follow up for cataracts.

David Barret
David Barret

Related posts:

  1. New threats emerging from Nipah Virus: Health Experts says
  2. Doctors From UAB Hospital Inform Seven Pregnant Women Are On Ventilators Due To Severe COVID19 Infection
  3. First Countrywide Data Shows COVID19 Shots Are Over 90 Percent Effective In Averting Deaths Linked To Delta Variant
  4. Scientists Claim Exposure To Some Common Human Coronaviruses Might Enhance Immunity Against COVID19

Filed Under: Health

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Three Incredible Telescopes Looked At The Butterfly Nebula To Learn Where Earth Came From
  • The Pacific Ocean Is So Vast It Contains Its Own Antipodes
  • World’s Tallest Bridge Over “Crack In The Earth” Gets Daunting Load Test By Fleet Of 96 Trucks
  • Mars’s Interior Still Has Evidence Of Ancient Impact, Dead NASA Mission Tells Us
  • A Soviet Physicist Once Survived A Proton Beam Through The Head – This Is How
  • Outstanding Photos Show First Baby Planet Growing In The Grooves Of A Stellar Disk
  • The “Plague Of Justinian” May Have Been The First Pandemic. DNA At A Mass Grave Has Finally Identified Its Cause.
  • Michelson And Morley’s “Failed” 1887 Experiment Changed The Course Of Physics, And Put The Aether To Bed
  • Only 19 US States Require School Sex Education To Be Medically Accurate, Finds Sweeping Review
  • Do Any Frogs Or Toads Give Birth To Live Young? Just One: Meet The Western Nimba Toad
  • Tasmanian Tigers’ Genetics May Have Doomed Them Long Before Humans Came Along
  • Scientists “Wake Up” Ancient Life That’s Been Under The Seabed For 100 Million Years
  • Measurable Brain Changes Following Cognitive Behavioral Therapy Identified For The First Time
  • “It Was Really Unexpected”: Scientists Stunned By Glowing Plants, And All It Takes Is An Injection
  • Scientists Created Gene-Edited Albino Cane Frogs To Unravel The Mysteries Of Natural Selection
  • In Vivo Vs In Vitro: What Do They Actually Mean?
  • IFLScience The Big Questions: What Will The Fossils Of The Future Look Like?
  • Finally, A Successful Starship Launch – What This Means For The Moon Landings
  • 26 Years After Launch, The ISS Will Try A New Way To Stay In Orbit Next Month
  • The World Map As You Know It Is Misleading – Now Africa Wants To Change That
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version